(Q37664214)

English

Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases.

scientific article published on January 2009

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

K M Hemsley

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

J J Hopwood

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

publication date

1 January 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

published in

International Journal of Clinical Pharmacology and Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

volume

47 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

page(s)

S118-23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

Identifiers

DOI

10.5414/CPP47118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

PubMed publication ID

20040322

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20040322

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20040322%20AND%20SRC:MED&resulttype=core&format=json

(Q37664214)

Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)